Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced …

…, J Mano, S Grumett, Z Stokes, KV Kamposioras… - JAMA …, 2021 - jamanetwork.com
Importance Older and/or frail patients are underrepresented in landmark cancer trials. Tailored
research is needed to address this evidence gap. Objective The GO2 randomized clinical …

Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: a meta-analysis

D Mauri, K Kamposioras, L Tsali, M Bristianou… - Cancer treatment …, 2010 - Elsevier
BACKGROUND: Taxanes have been extensively tested in patients with advanced breast
cancer, but it is unclear whether their weekly use might offer any benefits against standard …

Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysis

…, IP Polyzos, NP Polyzos, K Kamposioras… - Breast cancer research …, 2009 - Springer
To estimate the cumulative randomized evidence for the overall incidence of bisphosphonates
induced jaw osteonecrosis in adjuvant treatment of breast cancer. Systematic review and …

Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review

…, M Tsappi, S Tzioras, K Kamposioras… - Obstetrical & …, 2007 - journals.lww.com
The effect of combined vitamin C and E supplementation during pregnancy on the prevention
of preeclampsia and major adverse infant outcomes has been reviewed. We searched …

[HTML][HTML] Comparing health-related quality of life of cancer patients under chemotherapy and of their caregivers

I Vrettos, K Kamposioras, N Kontodimopoulos… - The Scientific World …, 2012 - hindawi.com
Introduction. Cancer is a major disorder physically and psychologically affecting both
patients and their caregivers. In this study, health-related quality of life (HRQoL) of patient-…

[HTML][HTML] The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration

S Banerjee, KHJ Lim, K Murali, K Kamposioras… - ESMO open, 2021 - Elsevier
Background The impact of the coronavirus disease 2019 (COVID-19) pandemic on well-being
has the potential for serious negative consequences on work, home life, and patient care. …

Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.

…, J Nicoll, S Cummings, SA Grumett, K Kamposioras… - 2019 - ascopubs.org
4006 Background: Many pts with aGOAC are elderly and/or frail. We previously compared
epirubin/ oxaliplatin/ capecitabine (EOCap) vs OCap vs Cap in a pick-the-winner study and …

[HTML][HTML] YAP/Hippo pathway and cancer immunity: it takes two to tango

D Matthaios, M Tolia, D Mauri, K Kamposioras… - Biomedicines, 2021 - mdpi.com
Hippo pathway with its main molecule YAP is a crucial pathway for development, tissue
homeostasis, wound healing, tissue regeneration, and cancer. In this review, we discuss the …

[HTML][HTML] Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic

D Mauri, K Kamposioras, M Tolia, F Alongi… - The Lancet …, 2020 - thelancet.com
Patients with cancer are at high risk for serious illness and death from COVID-19. The
pandemic has altered the routine for oncology patients. Their lives depend on their ability to …

Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks

K Kamposioras, G Pentheroudakis… - European journal of …, 2013 - Wiley Online Library
Background Cancer of unknown primary (CUP) ranks among the ten most common
malignancies worldwide. Cancer of unknown primary presents as disseminated disease, has a …